Search

QDX HealthID Signs Distribution Agreement with Innova Medical Group Inc.

QDX™ HealthID’s ecosystem now includes 6 of 12 FDA Emergency Use Authorized

rapid result COVID-19 tests


San Marcos, Texas, and Monrovia, Calif, Aug. 12, 2020 (GLOBE NEWSWIRE) -- QDX HealthID Incorporated, a wholly owned subsidiary of Quantum Materials Corp. (OTC Bulletin Board: QTMM) – today announced that, in conjunction with its parent, has signed a distribution agreement with Innova Medical Group Inc. (IMG), a wholly owned subsidiary of Pasaca Capital, Inc., for the inclusion of IMG’s rapid-result antigen and antibody tests, and PCR swab tests, in the QDX™ HealthID ecosystem of COVID-19 testing solutions.


QDX™ HealthID, currently in beta release, is a SaaS-based platform allowing companies and individuals to view and select a particular COVID-19 test kit, authenticate and record their test results in a secure way, and then share authenticated results with friends, family—or any other third party to share negative virus statuses.


READ MORE







#covid #coronavirus #covidsignals #InnovaMedicalGroup #QDXHealthID

© 2020 by COVIDSignals™